000 01395 a2200325 4500
005 20250514005423.0
264 0 _c20011018
008 200110s 0 0 eng d
022 _a0931-0509
024 7 _a10.1093/ndt/16.suppl_5.40
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSunder-Plassmann, G
245 0 0 _aNovel aspects of erythropoietin response in renal failure patients.
_h[electronic resource]
260 _bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_c2001
300 _a40-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnemia
_xblood
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aErythropoietin
_xadverse effects
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aRenal Insufficiency
_xchemically induced
650 0 4 _aTreatment Outcome
650 0 4 _aVitamins
_xtherapeutic use
700 1 _aHörl, W H
773 0 _tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_gvol. 16 Suppl 5
_gp. 40-4
856 4 0 _uhttps://doi.org/10.1093/ndt/16.suppl_5.40
_zAvailable from publisher's website
999 _c11434405
_d11434405